As Executive Director for the Translational Research Institute for Space Health (TRISH), Dorit Donoviel, Ph.D., leads a $0.25B NASA-funded innovation R&D program that finds, funds, and facilitates disruptive human health and performance solutions for astronauts traveling in deep space. In her previous role as deputy chief scientist of the National Space Biomedical Research Institute (NSBRI), Dr. Donoviel led both domestic and international research programs that bridged academic, industry, and government resources to deliver fast and cost-effective tangible results. Dr. Donoviel is an Associate Professor in the Department of Pharmacology and Chemical Biology and the Center for Space Medicine at Baylor College of Medicine (BCM) where she lectures and mentors graduate and medical students. She was recently named a BCM Woman of Excellence, was a long-time Faculty Senator, and was named a Health Policy Scholar for the Center for Medical Ethics and Health Policy at BCM. Dr. Donoviel received several awards from the NASA Human Research Program and is the recipient of the NSBRI Pioneer Award. Dr. Donoviel continues to author science thought leadership articles in academic journals as well as in the popular press.
